Similar articles

• Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.

  Tisdale M, Kemp SD, Parry NR, Larder BA. Tisdale M, et al. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5653-6. doi: 10.1073/pnas.90.12.5653. Proc Natl Acad Sci U S A. 1993. PMID: 7685907 Free PMC article.
• Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects.

  Boucher CA, O'Sullivan E, Mulder JW, Ramautarsing C, Kellam P, Darby G, Lange JM, Goudsmit J, Larder BA. Boucher CA, et al. J Infect Dis. 1992 Jan;165(1):105-10. doi: 10.1093/infdis/165.1.105. J Infect Dis. 1992. PMID: 1370174
• Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.

  Richman DD, Havlir D, Corbeil J, Looney D, Ignacio C, Spector SA, Sullivan J, Cheeseman S, Barringer K, Pauletti D, et al. Richman DD, et al. J Virol. 1994 Mar;68(3):1660-6. doi: 10.1128/JVI.68.3.1660-1666.1994. J Virol. 1994. PMID: 7509000 Free PMC article.
• HIV drug resistance.

  Richman DD. Richman DD. AIDS Res Hum Retroviruses. 1992 Jun;8(6):1065-71. doi: 10.1089/aid.1992.8.1065. AIDS Res Hum Retroviruses. 1992. PMID: 1503820 Review. No abstract available.
• Analysis of resistance mutants of viral polymerases.

  Oxford JS, al-Jabri AA, Stein CA, Levantis P. Oxford JS, et al. Methods Enzymol. 1996;275:555-600. doi: 10.1016/s0076-6879(96)75031-0. Methods Enzymol. 1996. PMID: 9026659 Review. No abstract available.